Informed Consent | Donor Confidentiality | Sample Traceability
Ethically Sourced Human Skin for Research
Genoskin develops ex vivo human skin models from residual tissue obtained during routine surgical procedures in France and the United States. This tissue, which would otherwise be discarded, is made available for scientific research only through established clinical partnerships and in accordance with applicable ethical, legal and institutional requirements.
Our sourcing approach is built around the protection of donor rights, confidentiality and human dignity, together with rigorous traceability and quality controls throughout the sample lifecycle. Human biological samples used by Genoskin are obtained only from individuals who have provided prior informed consent for their use in research.
From surgical donation to human skin model




1. Voluntary, informed donation
Human skin is obtained as residual tissue from routine surgical procedures such as abdominoplasty, brachioplasty and facelifts.
Before a sample is made available for research, the donor is informed of its intended scientific use and provides the required consent. Participation is voluntary and has no impact on the patient’s medical care.
Genoskin works with healthcare institutions under established agreements governing the collection and transfer of biological samples.
2. Protection of donor confidentiality
Genoskin does not receive information that directly identifies donors. Each sample is assigned a unique internal code, and the link to the donor’s identity remains with the healthcare provider.
We retain only information relevant to scientific use, sample characterization and quality control. Depending on the protocol, this can include age, sex, height and weight, relevant medical conditions, medications or treatments, anatomical site and other scientifically relevant sample characteristics.
This allows biologically meaningful donor variability to be considered without disclosing the donor’s identity.
3. No payment for donated tissue
Genoskin upholds the principle that the human body and its elements must not become a source of financial gain.
Donors receive no financial compensation for providing residual tissue for research.
The fees associated with Genoskin products and services relate to activities such as sourcing coordination, processing, quality control, model production, characterization, logistics and scientific services, rather than to the purchase of human tissue from donors.
Legal guidelines on the use of donated human skin tissue
Animal experiments have been widely used to assess toxicity and safety and to support the development of new pharmaceutical, chemical or cosmetic products. However, increasing awareness of the fate of laboratory animals has encouraged lawmakers to restrict the use of animals during testing procedures:


Legal & ethical compliance
Genoskin fully complies with ethical and legal standards:
Human data to de-risk drug development


At Genoskin, we provide innovative, animal-component-free (ACF) / xeno-free (XF) human skin models as reliable alternatives to animal testing. Instead of being discarded, the collected human skin is transformed into scientifically valuable tools that:
Our models support the biopharmaceutical, chemical, & cosmetic industries in developing safe and effective products, while actively reducing animal testing.
Our approach aims to improve drug development by generating relevant human data instead of relying on animal models. By using human skin tissue, our test platforms assess the immunogenicity and immunotoxicity of drugs and vaccines across different administration routes before clinical trials. This strategy provides more predictive results, helping science and industry move forward responsibly.


High-quality human skin data
Processed in compliance with ISO 9001 standards


To ensure our models and processes meet the standards and quality requirements of our customers, Genoskin SAS has obtained the ISO9001 certification. This validates the quality of our process management to deliver consistent, high-quality skin models and R&D services for the development of new drugs and products requiring human skin testing, with a team committed to being a trustworthy preclinical research partner. All our activities are documented in our quality assurance manual and periodically reviewed.


Since 2017, Genoskin’s main facility in France has been ISO9001:2015 certified, ensuring customers receive consistently high-quality products & services.
ISO9001 is a certifiable quality management system that can be used by any organization, regardless of its field of activity. This standard is based on several quality management principles, including:
Certified quality processes
Genoskin’s activities are divided into processes and monitored by demanding performance indicators


A robust documentary system oversees all of the company’s activities. Regular internal audits are carried out in parallel with external audits to ensure the proper application of our standard operating procedures and to maintain continuous improvement. The company is audited by AFNOR, an external certification body, yearly. All processes are verified (Sourcing/Biobanking, Production, Services, R&D, Sales, Quality, etc.). These audits are organized over a 3-year cycle: 1 initial audit and 2 follow-up audits.